Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. DNA Sequencing Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on DNA Sequencing Market

5.1. Covid-19: DNA Sequencing Industry Impact
5.2. DNA Sequencing Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and DNA Sequencing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for DNA Sequencing Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. DNA Sequencing Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Technological advances in next-generation sequencing technologies
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rising demand for precision medicine
6.1.3.2. Technological advancements

Chapter 7. Global DNA Sequencing Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. DNA Sequencing Market Revenue by Market Players
7.1.1.2. DNA Sequencing Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology, 2023-2032
9.1.1. Third Generation DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Next-Generation Sequencing
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Next-Generation Sequencing
9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global DNA Sequencing Market, By Application

10.1. DNA Sequencing Market, by Application, 2023-2032
10.1.1. Clinical Investigation
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Forensics & Agrigenomics
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Reproductive Health
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. HLA Typing
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global DNA Sequencing Market, By End Use

11.1. DNA Sequencing Market, by End-Use, 2023-2032
11.1.1. Clinical Research
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2021-2032)
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2021-2032)
11.1.4. Hospitals & Clinics
11.1.4.1. Market Revenue and Forecast (2021-2032)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2021-2032)
12.1.2. Market Revenue Forecast by Technology(2021-2032)
12.1.3. Market Revenue Forecast by Application (2021-2032)
12.1.4. Market Revenue Forecast by End-Use (2021-2032)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2032)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2032)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2021-2032)
12.2.2. Market Revenue Forecast by Technology (2021-2032)
12.2.3. Market Revenue Forecast by Application (2021-2032)
12.2.4. Market Revenue Forecast by End-Use (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2032)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2032)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2021-2032)
12.3.2. Market Revenue Forecast by Technology (2021-2032)
12.3.3. Market Revenue Forecast by Application (2021-2032)
12.3.4. Market Revenue Forecast by End-Use (2021-2032)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2032)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2032)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2021-2032)
12.4.2. Market Revenue Forecast by Technology (2021-2032)
12.4.3. Market Revenue Forecast by Application (2021-2032)
12.4.4. Market Revenue Forecast by End-Use (2021-2032)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2032)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2032)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2021-2032)
12.5.2. Market Revenue Forecast by Technology (2021-2032)
12.5.3. Market Revenue Forecast by Application (2021-2032)
12.5.4. Market Revenue Forecast by End-Use (2021-2032)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2032)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2032)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2032)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2032)

Chapter 13. Company Profiles

13.1. Agilent Technologies
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Illumina, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. QIAGEN
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Perkin Elmer
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Thermo Fisher Scientific
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Macrogen, Inc.
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Oxford Nanopore Technologies Ltd.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Myriad Genetics
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms